T. Rowe Price Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $536K | Buy |
|
|||||
|
2025
Q2 | $485K | Buy |
|
|||||
|
2025
Q1 | $592K | Buy |
|
|||||
|
2024
Q4 | $640K | Buy |
|
|||||
|
2024
Q3 | $633K | Buy |
|
|||||
|
2024
Q2 | $690K | Buy |
|
|||||
|
2024
Q1 | $469K | Buy |
|
|||||
|
2023
Q4 | $449K | Buy |
|
|||||
|
2023
Q3 | $527K | Buy |
|
|||||
|
2023
Q2 | $438K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $237K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $208K | Sell |
|
|||||
|
2021
Q2 | $335K | Sell |
|
|||||
|
2021
Q1 | $311K | Hold |
|
|||||
|
2020
Q4 | $286K | Sell |
|
|||||
|
2020
Q3 | $407K | Buy |
|
|||||
|
2020
Q2 | $461K | Hold |
|
|||||
|
2020
Q1 | $235K | Hold |
|
|||||
|
2019
Q4 | $854K | Buy |
|
|||||
|
2019
Q3 | $633K | Hold |
|
|||||
|
2019
Q2 | $710K | Hold |
|
|||||
|
2019
Q1 | $936K | Sell |
|
|||||
|
2018
Q4 | $1.01M | Hold |
|
|||||
|
2018
Q3 | $1.97M | Sell |
|
|||||
|
2018
Q2 | $21.5M | Buy |
|
|||||
|
2018
Q1 | $1.94M | Hold |
|
|||||
|
2017
Q4 | $1.96M | Sell |
|
|||||
|
2017
Q3 | $2.04M | Sell |
|
|||||
|
2017
Q2 | $5.23M | Sell |
|
|||||
|
2017
Q1 | $6.42M | Sell |
|
|||||
|
2016
Q4 | $8.75M | Buy |
|
|||||
|
2016
Q3 | $8.18M | Buy |
|
|||||
|
2016
Q2 | $7.78M | Sell |
|
|||||
|
2016
Q1 | $7.33M | Sell |
|
|||||
|
2015
Q4 | $7.47M | Sell |
|
|||||
|
2015
Q3 | $7.96M | Sell |
|
|||||
|
2015
Q2 | $9.99M | Sell |
|
|||||
|
2015
Q1 | $11.6M | Sell |
|
|||||
|
2014
Q4 | $15.8M | Sell |
|
|||||
|
2014
Q3 | $53.3M | Sell |
|
|||||
|
2014
Q2 | $114M | Buy |
|
|||||
|
2014
Q1 | $104M | Buy |
|
|||||
|
2013
Q4 | $24M | Sell |
|
|||||
|
2013
Q3 | $22M | Sell |
|
|||||
|
2013
Q2 | $20.3M | Buy |
|